Resources from the same session
TAX-TORC: An investigator initiated phase I study combining the dual mTORC1/2 inhibitor AZD2014 in combination with weekly paclitaxel in high-grade serous ovarian cancer
Presenter: Udai Banerji
Session: Developmental therapeutics
Resources:
Abstract
Phase I study of the pan-fibroblast growth factor receptor (FGFR) inhibitor BAY 1163877 with expansion cohorts for subjects based on tumor FGFR mRNA expression levels
Presenter: Markus Joerger
Session: Developmental therapeutics
Resources:
Abstract
Phase 1b study of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC)
Presenter: Colin Weekes
Session: Developmental therapeutics
Resources:
Abstract
Molecular imaging of PgP/BCRP inhibition at the blood brain barrier using elacridar and [11C]erlotinib PET
Presenter: Remy Verheijen
Session: Developmental therapeutics
Resources:
Abstract
Invited discussant abstracts 364PD and 365PD
Presenter: Christian Blank
Session: Developmental therapeutics
Resources:
Presentation
Webcast
Invited discussant abstracts 361PD, 362PD and 363PD
Presenter: Irene Braña
Session: Developmental therapeutics
Resources:
Presentation
Webcast
Invited discussant abstracts 357O and 358O
Presenter: Christophe Massard
Session: Developmental therapeutics
Resources:
Presentation
Webcast
Interim results from the completed first-in-human phase I dose escalation study evaluating MP0250, a multi-DARPin® blocking HGF and VEGF, in patients with advanced solid tumors
Presenter: Mark Middleton
Session: Developmental therapeutics
Resources:
Abstract
First-in-human study of AC0010, a novel irreversible, mutant-selective EGFR inhibitor in patients with 1st generation EGFR TKI-resistant non-small cell lung cancer (NSCLC)
Presenter: Li Zhang
Session: Developmental therapeutics
Resources:
Abstract
Anti-tumor activity of PEGylated human IL-10 (AM0010) in renal cancer alone and in combination with anti-PD1
Presenter: Aung Naing
Session: Developmental therapeutics
Resources:
Abstract